Dr Reddy's completes acquisition of Haleon's NRT portfolio
WEB14 hours ago · New Delhi: Dr Reddy's Laboratories on Monday said its Switzerland-based subsidiary has completed the acquisition of Haleon plc's global portfolio of consumer healthcare brands, outside of the US, in the Nicotine Replacement Therapy (NRT) category.
Dr Reddy's completes acquisition of UK co Haleon's non-US …
WEB10 hours ago · Hyderabad-based pharma giant Dr Reddy’s Ltd finalizes its largest acquisition by buying British Haleon Plc’s non-US nicotine replacement therapy (NRT) business for GBP 458 million. The deal includes brands like Nicotinell, thriving in 31 countries, and may involve contingent payments up to GBP 42 million. File photo.
Dr Reddy's completes acquisition of Haleon's NRT portfolio
WEB16 hours ago · Dr Reddy's Laboratories has acquired Haleon's global Nicotine Replacement Therapy (NRT) portfolio, excluding the US, for GBP 458 million. This includes top brands like Nicotinell, Nicabate, Thrive, and Habitrol, spanning over 30 countries.
Dr Reddy’s completes acquisition of Haleon Plc’s global portfolio …
WEB15 hours ago · Dr Reddy’s Laboratories SA, Switzerland, an arm of Dr Reddy’s Laboratories, has completed the previously-announced acquisition of Haleon Plc’s global portfolio of consumer healthcare brands...
Dr. Reddy's (RDY) to Acquire Haleon's Nicotine Addiction Drug
WEBJun 27, 2024 · Dr. Reddy’s Laboratories RDY has announced a definitive agreement with Haleon plc HLN to acquire its global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy (NRT)...
Haleon to sell nicotine replacement therapy business outside US …
WEBJun 26, 2024 · Haleon will sell its nicotine replacement therapy business outside the U.S. to a unit of India's Dr. Reddy's for 500 million pounds ($632.55 million), the British consumer healthcare...
Dr. Reddy's (RDY) to Acquire Haleon's Nicotine Addiction Drug
WEBJun 27, 2024 · Dr. Reddy’s Laboratories RDY has announced a definitive agreement with Haleon plc HLN to acquire its global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy (NRT)...
Dr. Reddy's to Acquire Haleon's Nicotine Addiction Drug
WEBJun 27, 2024 · Dr. Reddy's Laboratories (NYSE:RDY) has announced a definitive agreement with Haleon plc (NYSE:HLN) to acquire its global portfolio of consumer healthcare brands in the Nicotine Replacement...
Haleon to Sell Nicotine-Quitting Aid Business for $634 Million
WEBJun 26, 2024 · Haleon will sell a significant portion of its nicotine-quitting aid business to Dr. Reddy's Laboratories, an India-based pharmaceutical company, in a 500 million-pound ($634.2 million) deal.
Haleon sells nicotine replacement drug to Dr. Reddy's for $633M
WEBJun 26, 2024 · Haleon has continued its push to divest, selling its nicotine replacement therapy (NRT) business outside of the United States to Dr. Reddy’s for 500 million pounds ($633 million).
- Some results have been removed